Brian D. Sippy

Ophthalmology
700 W Kent Ave
Missoula, MT 59801

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

Journal: Ophthalmic surgery, lasers & imaging retina
Published: December 21, 2017
Showing 1-1 of 1

Last Updated: 09/26/2026